Kura Oncology, Inc. (KURA)
12.40
+0.51
(+4.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.12
+0.72
(+5.81%)
After-Hours: 20:00
Kura Oncology Debt to Equity Ratio : 0.5049 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5049 |
| March 31, 2026 | 0.225 |
| December 31, 2025 | 0.1175 |
| September 30, 2025 | 0.0803 |
| June 30, 2025 | 0.0637 |
| March 31, 2025 | 0.0531 |
| December 31, 2024 | 0.0401 |
| September 30, 2024 | 0.0392 |
| June 30, 2024 | 0.0359 |
| March 31, 2024 | 0.0336 |
| December 31, 2023 | 0.0433 |
| September 30, 2023 | 0.0405 |
| June 30, 2023 | 0.0284 |
| March 31, 2023 | 0.0343 |
| December 31, 2022 | 0.0334 |
| September 30, 2022 | 0.0128 |
| June 30, 2022 | 0.0131 |
| March 31, 2022 | 0.0134 |
| December 31, 2021 | 0.0136 |
| September 30, 2021 | 0.0138 |
| June 30, 2021 | 0.0121 |
| March 31, 2021 | 0.0235 |
| December 31, 2020 | 0.0245 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0503 |
| June 30, 2020 | 0.0473 |
| March 31, 2020 | 0.0478 |
| December 31, 2019 | 0.0354 |
| September 30, 2019 | 0.0337 |
| June 30, 2019 | 0.0324 |
| March 31, 2019 | 0.0541 |
| December 31, 2018 | 0.0466 |
| September 30, 2018 | 0.0359 |
| June 30, 2018 | 0.062 |
| March 31, 2018 | 0.0573 |
| December 31, 2017 | 0.0889 |
| September 30, 2017 | 0.0789 |
| June 30, 2017 | 0.1685 |
| March 31, 2017 | 0.1461 |
| December 31, 2016 | 0.1288 |
| September 30, 2016 | 0.1148 |
| June 30, 2016 | 0.1041 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.831 |
| Fortress Biotech, Inc. | 0.3248 |
| Syndax Pharmaceuticals, Inc. | 39.03 |
| Spero Therapeutics, Inc. | 0.0462 |
| Gossamer Bio, Inc. | -0.4261 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 587.79M |
| Total Liabilities (Quarterly) | 539.36M |
| Shareholders Equity (Quarterly) | 48.43M |
| Current Ratio | 4.733 |
| Net Debt Paydown Yield | -0.10% |